Stay updated on Abaloparatide-Solid Microstructured Transdermal System Clinical Trial
Sign up to get notified when there's something new on the Abaloparatide-Solid Microstructured Transdermal System Clinical Trial page.

Latest updates to the Abaloparatide-Solid Microstructured Transdermal System Clinical Trial page
- Check5 days agoChange DetectedUI updates add a Show glossary option and normalize capitalization for QC-related labels (Last Update Submitted that Met QC Criteria) and No FEAR Act Data, plus a new Revision: v3.4.0 note. The previous labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) are removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; this is a minor version change and does not affect study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedLocations section updated: new state entries added and existing state entries removed. This changes which sites are listed for the study and where potential participants can enroll.SummaryDifference2%

- Check69 days agoChange DetectedPublications section wording updated to indicate PubMed automatically populates entries and may not reflect the study; site footer revision updated to v3.3.2.SummaryDifference0.1%

- Check76 days agoChange DetectedRemoved the government funding notice about potential delays and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check90 days agoChange DetectedThe changes are limited to non-substantive UI adjustments (spacing, header styling, and a possible modal/banner); core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Abaloparatide-Solid Microstructured Transdermal System Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abaloparatide-Solid Microstructured Transdermal System Clinical Trial page.